US 8298576
Sustained-release formulations of topiramate
granted A61KA61K31/357A61K31/7048
Quick answer
US patent 8298576 (Sustained-release formulations of topiramate) held by Supernus Pharmaceuticals, Inc. expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/357, A61K31/7048, A61K45/06, A61K47/6951